Neuraxial Use Among Total Knee and Hip Arthroplasty Patients With Multiple Sclerosis or Myasthenia Gravis
- 20 March 2023
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Anesthesia & Analgesia
- Vol. 136 (6), 1182-1188
- https://doi.org/10.1213/ane.0000000000006471
Abstract
BACKGROUND: Surgical patients with preexisting neurological diseases create greater challenges to perioperative management, and choice of anesthetic is often complicated. We investigated neuraxial anesthesia use in total knee and hip arthroplasty (TKA/THA) recipients with multiple sclerosis or myasthenia gravis compared to the general population. METHODS: We retrospectively analyzed patients undergoing a TKA/THA with a diagnosis of multiple sclerosis or myasthenia gravis (Premier Health Database, 2006–2019). The primary outcome was neuraxial anesthesia use in multiple sclerosis or myasthenia gravis patients compared to the general population. Secondary outcomes were length of stay, intensive care unit admission, and mechanical ventilation. We measured the association between the aforementioned subgroups and neuraxial anesthesia use. Subsequently, subgroup-specific associations between neuraxial anesthesia and secondary outcomes were measured. We report odds ratios (ORs) and 95% confidence intervals (CIs). RESULTS: Among 2,184,193 TKA/THAs, 7559 and 3176 had a multiple sclerosis or myasthenia gravis diagnosis, respectively. Compared to the general population, neuraxial anesthesia use was lower in multiple sclerosis patients (OR, 0.61; CI, 0.57–0.65; P < .0001) and no different in myasthenia gravis patients (OR, 1.05; CI, 0.96–1.14; P = .304). Multiple sclerosis patients administered neuraxial anesthesia (compared to those without neuraxial anesthesia) had lower odds of prolonged length of stay (OR, 0.63; CI, 0.53–0.76; P < .0001) mirroring neuraxial anesthesia benefits seen in the general population. CONCLUSIONS: Neuraxial anesthesia use was lower in surgical patients with multiple sclerosis compared to the general population but no different in those with myasthenia gravis. Neuraxial use was associated with lower odds of prolonged length of stay.This publication has 20 references indexed in Scilit:
- Multiple sclerosis: basic knowledge and new insights in perioperative managementJournal of Anesthesia, 2013
- Obstetrical epidural and spinal anesthesia in multiple sclerosisZeitschrift für Neurologie, 2013
- Perioperative Comparative Effectiveness of Anesthetic Technique in Orthopedic PatientsAnesthesiology, 2013
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational StudiesMultivariate Behavioral Research, 2011
- First, do no harm: balancing the risks and benefits of regional anesthesia in patients with underlying neurological diseaseCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2008
- Anaesthetic considerations for patients with a pre‐existing neurological deficit: are neuraxial techniques safe?Acta Anaesthesiologica Scandinavica, 2007
- Neuraxial Anesthesia and Analgesia in Patients with Preexisting Central Nervous System DisordersAnesthesia & Analgesia, 2006
- The Epidemiology of Myasthenia GravisSeminars in Neurology, 2004
- Neurologic Complications of Spinal and Epidural AnesthesiaRegional Anesthesia & Pain Medicine, 2000
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992